Prion diseases

Journal of NeuroVirology

Volumn 9, Issue 2, 2003, Pages 183-193

  McKintosh, Edward ^a   Tabrizi, Sarah J ^a   Collinge, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bovine spongiform encephalopathy; Creutzfeldt Jakob disease; Fatal familial insomnia; Gerstmann Straussler Scheinker syndrome; Kuru; Prion; Scrapie; Spongiform encephalopathy

Indexed keywords

BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; EPIDEMIC; FATAL FAMILIAL INSOMNIA; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; INHERITANCE; KURU; MEDICAL RESEARCH; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM; VIRUS STRAIN;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0038813672     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280390194082     Document Type: Review

References (74)

1. Alper T (1993). The scrapie enigma: insights from radiation experiments. Radiat Res 135: 283-292.
2. Alper T, Cramp WA, Haig DA, Clarke MC (1967). Does the agent of scrapie replicate without nucleic acid? Nature 214: 764-766.
3. Alper T, Haig DA, Clarke MC (1966). The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 22: 278-284.
4. Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood A, Welch J, Hill AF, Lloyd SE, Wadsworth JDF, Collinge J (2002). BSE prions propagae as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J, 21: 6358-6366.
5. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Coughey B (1995). Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375: 698-700.
6. Bessen RA, Marsh RF (1992). Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66: 2096-2101.
7. Bessen RA, Marsh RF (1994). Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68: 7859-7868.
8. Bolton DC, McKinley MP, Prusiner SB (1982). Identification of a protein that purifies with the scrapie prion. Science 218: 1309-1311.
9. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, et al (1997). The cellular prion protein binds copper in vivo. Nature 390: 684-687.
10. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM (1999). Normal prion protein has an activity like that of superoxide dismutase. Biochemical J 344: 1-5.
11. Brown P, Cervenakova L, Goldfarb MD, McCombie WR, Rubenstein R, Will RG, et al (1994). Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 44: 291-293.
12. Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H (1994). Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond [Biol] 343: 405-411.
13. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al (1993). Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347.
14. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp H-P, DeArmond SJ, et al (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature, 356: 577-582.
15. Clavel M, Clavel P (1996). Creutzfeldt-Jakob disease transmitted by dura mater graft. Eur Neurol 36: 239-240.
16. Collinge J (1999). Variant Creutzfeldt-Jakob disease. Lancet 354: 317-323.
17. Collinge J, Brown J, Hardy J, Mullan M, Rossor MN, Baker H, et al (1992). Inherited prion disease with 144 base pair gene insertion: II: Clinical and pathological features. Brain 115: 687-710.
18. Collins SJ, Lewis V, Brazier M, Hill AF, Fletcher A, Masters CL (2002). Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neurol 52: 503-506.
19. Collinge J, Palmer MS, Dryden AJ (1991). Genetic predisposition to Iatrogenic Creutzfeldt-Jakob disease. Lancet 337: 1441-1442.
20. Collinge J, Palmer MS, Sidle KCL, Gowland I, Medori R, Ironside J, et al (1995). Transmission of fatal familial insomnia to laboratory animals. Lancet 346: 569-570.
21. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF (1996). Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383: 685-690.
22. Creutzfeldt HG (1920). Uber eine eigenartige herdfoermige Erkrankung des Zentralnervensystems. Z Gesamte Neurol Psychiatry 57: 1-18.
23. Dodelet VC, Cashman NR (1998). Prion protein expression in human leukocyte differentiation. Blood 91: 1556-1561.
24. Ehlers B, Diringer H (1984). Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J Gen Virol 65: 1325-1330.
25. Farquhar CF, Dickinson AG (1986). Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J Gen Virol 67: 463-473.
26. Fischer M, Rulicke T, Raber A, Sailer A, Oesch B, Brandner S, et al (1996). Prion protein (PrP) with amino terminal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15: 1255-1264.
27. Gajdusek DC, Gibbs CJ Jr, Alpers MP (1966). Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209: 794-796.
28. Gambetti P, Petersen R, Monari L, Tabaton M, Autilio-Gambetti L, Cortelli P, et al (1993). Fatal familial insomnia and the widening spectrum of prion diseases. Br Med Bull 49: 980-994.
29. Ghani AC (2002). The epidemiology of variant Creutzfeldt-Jakob disease in Europe. Microb Infect 4: 385-393.
30. Ghani AC, Ferguson NM, Donnelly CA, Hagenaars TJ, Anderson RM (1999). Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proc R Soc Lond B 265: 2443-2452.
31. Gibbs CJ Jr, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC (1994). Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatiy 57: 757-758.
32. Gottesdiener KM (1989). Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 110: 1001-1016.
33. Griffith JS (1967). Self Replication and scrapie. Nature 215: 1043-1044.
34. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, et al (1999). Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353: 183-189.
35. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J (1997a). The same prion strain causes vCJD and BSE. Nature 389: 448-450.
36. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J (2000). Species barrier independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 97: 10248-10253.
37. Hill AF, Zeidler M, Ironside J, Collinge J (1997b). Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349: 99-100.
38. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Penney M, et al (2002). Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 325: 633-634.
39. Hornshaw MP, McDermott Jr, Candy JM, Lakey JH (1995). Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 214: 993-999.
40. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, et al (1989). Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338: 342-345.
41. Ingrosso L, Ladogana A, Pocchiari M (1995). Congo red prolongs the incubation period in scrapie-infected hamsters. J Virol 69: 506-508.
42. Ironside JW, Head MW, Bell JE, McCardle L, Will RG (2000). Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 37: 1-9.
43. Jackson GS, Murray I, Hosszu LL, Gibbs N, Waltho JP, Clarke AR, et al (2001). Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci USA 98: 8531-8535.
44. Jakob A (1921). Uber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befund. Z Gesamte Neurol Psychiatry 64: 147-228.
45. Kellings K, Prusiner SB, Riesner D (1994). Nucleic acids in prion preparations: unspecific background or essential component. Philos Trans R Soc Lond [Biol] 343: 425-430.
46. Kennedy RH, Hogan N, Brown P, Holland E, Johnson RT, Stark W, et al (2001). Eye banking and screening for Creutzfeldt-Jakob disease. Arch Ophthalmol 119: 721-726.
47. Kimberlin RH, Walker CA (1979). Pathogenesis of scrapie: agent multiplication in brain at the first and second passage of hamster scrapie in mice. J Gen Virol 42: 107-117.
48. Kimberlin RH, Walker CA (1986). Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrob Agents Chemother 30: 409-413.
49. Kretzschmar HA, Neumann M, Stavrou D (1995). Codon 178 mutation of the human prion protein gene in a German family (Backer family): sequencing data from 72- year-old celloidin-embedded brain tissue. Acta Neuropathol (Berl) 89: 96-98.
50. Laplanche J-L, Delasnerie-Lauprêtre N, Brandel JP, Chatelain J, Beaudry P, Alpérovitch A, et al (1994). Molecular genetics of prion diseases in France. French Research Group on Epidemiology of Human Spongiform Encephalopathies. Neurology 44: 2347-2351.
51. Lugaresi E, Medori R, Baruzzi PM, Cortelli P, Lugaresi A, Tinupar P, et al (1986). Fatal familial insomnia and dysautonomia, with selective degeneration of thalamic nuclei. N Engl J Med 315: 997-1003.
52. Mallucci GR, Ratté S, Asante EA, Linehan J, Gowland I, Jefferys JGR, et al (2002). Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 21: 202-210.
53. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J (1994). 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8: 121-127.
54. Manson J, West JD, Thomson V, McBride P, Kaufman MH, Hope J (1992). The prion protein gene: a role in mouse embryogenesis? Development 115: 117-122.
55. Mastrianni JA, Iannicola C, Myers RM, DeArmond S, Prusiner SB (1996). Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease. Neurology 47: 1305-1312.
56. McGowan JP (1922). Scrapie in sheep. Scott J Agric 5: 365-375.
57. Medori R, Tritschler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, et al (1992a). Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene [see comments]. N Engl J Med 326: 444-449.
58. Medori R, Montagna P, Tritschler HJ, LeBlanc A, Cortelli P, Tinupar P, et al (1992b). Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 42: 669-670.
59. Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991). Hemozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352: 340-342.
60. Pattison IH (1965). Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease. In: Slow latent and temperate virus infections, NINDB Monograph 2. Gajdusek CJ, Gibbs CJ, Alpers MP (eds). Washington DC: US Government Printing, p. 249-257.
61. Prusiner SB, Bolton DC, Groth DF, Bowman K, Cochran SP, Mc Kinley MP (1982). Further purification and characterization of scrapie prions. Biochemistry 21: 6942-6950.
62. Prusiner, SB (1982). Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
63. Prusiner SB et al; Rubin E et al; Stanton BR et al (1990). D 216. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. D 217. Production of human hemoglobin S antilles in transgenic mice. D 218. Analysis of murine Nmyc function by in situ hydridization and homologous recombination. J Cellular Biochem UCLA Symposium Suppl 14A: 363.
64. Rappaport EB, Graham DJ (1987). Pituitary growth hormone from human cadavers: neurologic disease in ten recipients. Neurology 37: 1211-1213.
65. Salvatore M, Genuardi M, Petraroli R, Masullo C, D'Alessandro M, Pocchiari M (1994). Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease. Hum Genet 94: 375-379.
66. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Wälchli M, et al (1989). Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59: 847-857.
67. Shyng S-L, Heuser JE, Harris DA (1994). A glycolipid-anchored prion protein is endocytosed via clathrincoated pits. J Cell Biol 125: 1239-1250.
68. Soto C, Kascsack RJ, Saborío GP, Aucouturier P, Wisniewski T, Prelli F, et al (2000). Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet 355: 192-197.
69. Stöckel J, Safar J, Wallace AC, Cohen FE, Prusiner SB (1998). Prion protein selectively binds copper(II) ions. Biochemistry 37, 7185-7193.
70. Tagliavini F, McArthur RA, Canciani B, Giaccone G, Porro M, Bugiani M, et al (1997). Effectiveness of anthracycline against experimental prion disease in syrian hamsters. Science 276: 1119-1122.
71. Tateishi J, Brown P, Kitamoto T, Hoque ZM, Roos R, Wollman R, et al (1995). First experimental transmission of fatal familial insomnia. Nature 376: 434-435.
72. Wadsworth JDF, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J (1999). Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1: 55-59.
73. Wadsworth JDF, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, et al (2001). Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay. Lancet 358: 171-180.
74. Weissmann C (1991). A 'unified theory' of prion propagation. Nature 352: 679-683.